|
The Pharmacy Quality Assurance Commission (commission / PQAC) requires that an individual who is enrolled in a commission-approved pharmacy technician training program shall obtain an endorsement for the experiential training in the pharmacy per WAC 246-945-203.
Before beginning a pharmacy technician training program, an individual must apply to become a pharmacy assistant and obtain the technician-in-training endorsement. Application must include verification of enrollment in a commission approved pharmacy technician training program. Proof of enrollment form must be completed and submitted by the approved training director. More detail can be found under Section 4: Pharmacy technician in Training Enrollment form.
Pharmacy personnel license applications and forms must be submitted to: HSQAReview2@doh.wa.gov. If you have any questions, please contact personnel credentialing via the email or by calling (360) 236-4986.
PQAC has received inquiries from stakeholders seeking to understand if a pharmacy may compound veterinary drugs from bulk drug substances (BDS) for a veterinarian to use as office stock for nonfood-producing animals. At the July 2022 business meeting, the commission determined:
While the U.S. Food and Drug Administration’s Guidance for Industry #256 would permit “a pharmacist in a state-licensed pharmacy or federal facility” to compound animal drugs from BDS for office stock for nonfood-producing animals under certain conditions, Washington law restricts the ability of a pharmacist in a state-licensed pharmacy from compounding animal drugs from BDS for office stock for nonfood-producing animals. This is because compounding any drug for office stock is generally considered to be manufacturing and requires a manufacturer license (RCW 18.64.011(21) and (22)). There are exceptions to this general rule in RCW 18.64.011(21), which provide that a pharmacy may engage in the following conduct without being licensed as a manufacturer:
- The activities of a licensed pharmacy that compounds a product on or in anticipation of an order of a licensed practitioner for use in the course of their professional practice to administer to patients, either personally or under their direct supervision;
- The practice of a licensed pharmacy when repackaging commercially available medication in small, reasonable quantities for a practitioner legally authorized to prescribe the medication for office use only;
- The distribution of a drug product that has been compounded by a licensed pharmacy to other appropriately licensed entities under common ownership or control of the facility in which the compounding takes place; or
- The delivery of finished and appropriately labeled compounded products dispensed pursuant to a valid prescription to alternate delivery locations, other than the patient's residence, when requested by the patient, or the prescriber to administer to the patient, or to another licensed pharmacy to dispense to the patient.
Additionally, “drugs” are defined in chapter 18.64 RCW as “Substances intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in human beings or other animals” (RCW 18.64.011(14)(b)).
Washington law only permits a pharmacy to compound animal drugs from BDS for a veterinarian as office stock for nonfood-producing animals if one of the exceptions in RCW 18.64.011(21) listed above applies, or if the pharmacy obtained a manufacturer license.
DOH and the office of Infectious Disease invites you to attend the final session in their Pharmacy-based PrEP Program Series. Click to find out more and register for the Friday, September 9, lunchtime session.
The Washington Department of Health (DOH) permanently closed the office located in Kent on August 31, 2022. The fax number and physical mailing address should no longer be used. Please refer to the table below to update your files.
Those individuals and facilities wishing to fax the Department’s Office of Investigative and Legal Services (OILS) for investigative matters should fax the Tumwater OILS at (360) 236-4930. Mandatory reports should be submitted to Health Systems Quality Assurance (HSQA) Complaint Intake at HSQAComplaintIntake@doh.wa.gov.
Reports intended for the PQAC, including Controlled Substance Loss Reports and DEA 106 forms, should be emailed to WSPQAC@doh.wa.gov or may be faxed to (360) 236-2260.
Licensure application materials and forms intended for HSQA Credentialing should be sent to HSQAFC@doh.wa.gov (for submitting documentation related to facilities) or HSQAReview2@doh.wa.gov (for submitting documentation related to personnel).
The phone number for Facilities Credentialing is (360) 236-4985. The phone number for Personnel Credentialing is (360) 236-4986.
Pharmacy personnel licensure applications are currently being updated on the WA DOH website. Interested parties may find submitting online applications allows for more efficient and timely processing.
FOR QUICK REFERENCE
| Where do I email… |
DEA 106 Forms |
WSPQAC@doh.wa.gov |
| Controlled Substance Loss Reports |
WSPQAC@doh.wa.gov |
| Mandatory Reports |
HSQAComplaintIntake@doh.wa.gov |
| Change in Responsible Pharmacy Manager Forms |
HSQAFC@doh.wa.gov |
| Drug Samples Loss Reports |
WSPQAC@doh.wa.gov |
| Name Changes on Credentials |
hsqa.csc@doh.wa.gov |
| How do I reach... |
PQAC E-mail |
WSPQAC@doh.wa.gov |
| PQAC Main Phone |
(360) 236-4946 |
| PQAC Fax |
(360) 236-2260 |
| HSQA Credentialing (Facilities) E-mail |
HSQAFC@doh.wa.gov |
| HSQA Credentialing (Facilities) Phone |
(360) 236-4985 |
| HSQA Credentialing (Personnel) |
HSQAReview2@doh.wa.gov |
| HSQA Credentialing (Personnel) Phone |
(360) 236-4986 |
| Office of Investigative and Legal Services (OILS) Phone |
(360) 236-4930 |
| How do I update... |
Contact, Address, or Personal Status Information |
Survey (wa.gov) |
| Where do I mail... |
Fee Payment(s) to the WA DOH
(including any corresponding forms)
|
HSQA-CSC
PO Box 1099
Olympia WA 98507-1099
|
| Request to Change Pharmacist License Status to Retired |
HSQA-CSC
PO Box 1099
Olympia WA 98507-1099
|
The July 2022 issue of the PQAC's quarterly newsletter is now available. The newsletter is published in collaboration with the National Association of Boards of Pharmacy to protect public health and promote compliance with laws, rules, and regulations pertaining to the practice of pharmacy.
• 1404 Updated Policy Statement on USP and Now Available
• 1405 Potential Risks of Compounded Ketamine Nasal Spray
• 1406 Pharmacy Technician Remote Work FAQ
• 1407 Beware of Ongoing Scam Attempts
• 1408 Permanent Rule Filing Epidiolex Rule Adoption (CR-103p) Filed
• 1409 Emergency Rules Filings
|
